LIXTE Biotech files complex 8-K with 8 item types

FilingFirehose Daily · · 10 filings flagged · archive · RSS

Yesterday saw 242 8-K filings, 12 shelf registrations, and 9 S-3s across U.S. markets.

Top 3

  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. (CIK 1335105): Eight-item 8-K with buried restructuring signals—items 1.01, 2.01 folded into 7.01 and 9.01, suggesting complexity in deal or governance disclosure.
  • Pyxis Oncology, Inc. (CIK 1782223): Filed 1.01/3.02/7.01 but omitted 9.01 from header despite document evidence—discrepancy flags potential material event underreporting.
  • ALPHA MODUS HOLDINGS, INC. (CIK 1862463): Completion of transaction (2.03) and 1.01 cost-basis shift (buried under 3.01) suggests acquisition or spin-related charge.

Paid subscribers see 7 more flagged filings + sector signals — upgrade for $9/mo

FilingFirehose Daily · 2026-07-03

Paid subscribers see 7 more flagged filings + cross-sector signal

Upgrade for $9/mo →

Free tier: top 3 filings every morning. One-click unsubscribe. No spam.